Concert Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Concert Pharmaceuticals

Access the complete profile.

Concert Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	65 Hayden Avenue Suite 3000n Lexington, MA 02421

Concert Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Concert Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Concert Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Concert Pharmaceuticals is a publicly traded company on NGM using the ticker symbol CNCE. Detailed information on company financials and operating reports can be found here: NGM: CNCE

Concert Pharmaceuticals Annual Revenue and Growth Rate

Concert Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Concert Pharmaceuticals's revenues are gauged from an analysis of company filings.

Trademark Applications

Trademark applications show the products and services that Concert Pharmaceuticals is developing and marketing. Concert Pharmaceuticals doesn't have any recent trademark applications, indicating Concert Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
LEQSELVI Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis; none of the aforesaid being pharmaceuticals for the treatment of cardiovascular diseases	02/02/2021
RENZYNCE Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis	02/02/2021
RAYFOLAA Pharmaceutical preparations for the treatment of autoimmune, gastrointestinal, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for the treatment of hair loss disorders; pharmaceutical preparations, namely, medicated dermatological preparations; pharmaceutical preparations for the treatment of alopecia areata, atopic dermatitis, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis	02/02/2021

See all trademarks and details in the Full Report.

Market Share of Concert Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Concert Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Concert Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Other Companies at 65 Hayden Avenue, Lexington MA

Company	Headquarters	Revenue ($ MM)
CUBIST PHARMACEUTICALS	Lexington, MA	100
ACCENT THERAPEUTICS	Lexington, MA	8

Future Competition: Concert Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Concert Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)